Hyperreactivity of Platelets to Serotonin (5-Hydroxytryptamine) in Patients with Cardiovascular Diseases

This publication has 9 references indexed in Scilit:

• Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.
  Hypertension, 1988
• The effect of ketanserin, a 5-HT2-receptor antagonist, on 5-hydroxytryptamine-induced irreversible platelet aggregation in patients with cardiovascular diseases
  Inflammation Research, 1985
• PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF KETANSERIN IN TREATMENT OF INTERMITTENT CLAUDICATION
  The Lancet, 1984
• Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs
  JAMA, 1983
• Platelet-mediated vascular contractions: Inhibition of the serotonergic component by ketanserin
  Thrombosis Research, 1982
• Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors
  Life Sciences, 1981
• Platelet Aggregates in Ischemic Heart Disease
  Thrombosis and Haemostasis, 1980
• Adenosine diphosphate induced platelet aggregation in myocardial infarction and ischemic heart disease
  Atherosclerosis, 1973
• A Biphasic Response of Platelets to Serotonin
  Scandinavian Journal of Haematology, 1970